Author:
Wertman Jaime,Veinotte Chansey J.,Dellaire Graham,Berman Jason N.
Publisher
Springer International Publishing
Reference80 articles.
1. Sharpless NE, Depinho RA (2006) The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 5:741–754
2. Cariati M, Marlow R, Dontu G (2011) Cancer cell culture. Methods Mol Biol 731:471–482
3. Voskoglou-Nomikos T, Pater JL, Seymour L (2003) Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res 9:4227–4239
4. Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, McLaren K, Matthews L, McLaren S, Sealy I, Caccamo M, Churcher C, Scott C, Barrett JC, Koch R, Rauch G-J, White S, Chow W, Kilian B, Quintais LT, Guerra-Assunção JA, Zhou Y, Gu Y, Yen J, Vogel J-H, Eyre T, Redmond S, Banerjee R et al (2013) The zebrafish reference genome sequence and its relationship to the human genome. Nature 496:498–503
5. Agliano A, Martin-Padura I, Mancuso P, Marighetti P, Rabascio C, Pruneri G, Shultz LD, Bertolini F (2008) Human acute leukemia cells injected in NOD/LtSz-scid/IL-2R?? null mice generate a faster and more efficient disease compared to other NOD/scid-related strains. Int J Cancer 123(August):2222–2227
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献